7-(Chloromethyl)-3,4-dihydro-2H-benzo[b][1,4]dioxepine, 95.0%, 1g

(R)-Morpholine-2-carboxylic acid hydrochloride, 95.0%, 10g

10-Methoxy-5H-dibenz[b,f]azepine, 95.0%, 5g

5-Bromo-4-chlorothiophene-2-carboxylic acid, 95.0%, 500mg

GC capillary column ROTI®Cap-5, 60 m, 0.32 mm, 0.25 µm, 1 Piece(s)

2-Chloro-5-(trifluoromethyl)pyrimidin-4-amine, 95.0%, 1g

3-tert-Butyl-1-methyl-1H-pyrazole-5-carboxylic acid, 95.0%, 50g

Synephrine Tartrate>98.0%(HPLC)(T)25g

1,1,1,2,2,4,5,5,5-Nonafluoro-4-(trifluoromethyl)-3-pentanone>98.0%(GC)100g

5,6-Diamino-1-methyluracil, 95.0%, 5g

Tetrahydro-2H-thiopyran-4-ol>98.0%(GC)5g

7-Methylpyrazolo[1,5-a][1,3,5]triazin-4(3H)-one, 95.0%, 100mg

Trisodium Naphthalene-1,3,6-trisulfonate>65.0%(HPLC)500g